Mechanisms of primary and secondary resistance to RET inhibitors in patients with RET-positive advanced NSCLC
Authors
Marinello, A.Vasseur, D.
Conci, N.
Fallet, V.
Audigier-Valette, C.
Cousin, S.
Tabbo, F.
Guisier, F.
Russo, A.
Blanco, A. C.
Metro, G.
Massa, G.
Citarella, F.
Eisert, A. K.
Gomez, P. I.
Tagliamento, M.
Mezquita, L.
Lindsay, Colin R
Ponce, S.
Aldea, M.
Affiliation
Medical Oncology Department, Institut Gustave Roussy, Villejuif, France; 2 Molecular Biology, Gustave Roussy - Cancer Campus, Villejuif, France;Issue Date
2022
Metadata
Show full item recordCitation
Marinello A, Vasseur D, Conci N, Fallet V, Audigier-Valette C, Cousin S, et al. Mechanisms of primary and secondary resistance to RET inhibitors in patients with RET-positive advanced NSCLC. Annals of Oncology. 2022 Sep;33(7):S1013-S4. PubMed PMID: WOS:000866211601272.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.07.1133Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.1133Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.07.1133